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DLimitations of the Study
This study has several limitations. It is a retrospective anal-
ysis of many patients undergoing operations over a long pe-
riod of time, when techniques, strategies, and experience
progressively increased and improved, and the retrospective
nature of this study causes, by definition, a selection bias.
Moreover, this article reports the evolution of a concept
across time, starting from the volume reduction toLV reshap-
ing, and therefore although its retrospective nature represents
a limitation, we believe that a retrospective study is the only
chance we had to report our experience. Being retrospective,
some preoperative data are missing (ie, wall motion data,
right ventricular function, description of any coronary lesion,
and conicity index) or incomplete, and therefore a complete
vision of the preoperative status of the patients was not pos-
sible in some cases. Furthermore, the echocardiographic as-
sessment was possible in only 45% of the patients. We were
not able to confirm that this new surgical technique resulted
in a different ventricle than the previous surgical technique
used by us late after surgical intervention because we did
not have a consistent echocardiographic follow-up.
Most descriptions of the effect of shape on function are
only experimental or rely on assumptions never validated
in human diseased hearts. The notion that myofibril orienta-
tion changes within a remote segment of myocardium with
the development of dilation in response to an anterior infarc-
tion has never been demonstrated in vivo.14CONCLUSION
Long-term results after LVSR are satisfying but in our ex-
perience seem to be better if a conical shape is rebuilt. The
designation of V and S groups represents different patient
groups, and the more recent group fared better than the early
group. Future studies will be required to determine whether
the attempt to reshape the ventricle was successful and influ-
enced the outcome. An unsolved question is how to establish
the limits of LVSR (eg, grade of preoperative diastolic dys-
function, diastolic diameter, ventricular volume, and func-
tion of the remote zone). The role of each treatment for the
single patient (medical treatment, CABG alone, and
CABG and LVSR) is still to be identified.References
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Dr Lorenzo A. Menicanti (Milan, Italy). I have no conflict of
interest.
I want to congratulate Antonio for this very interesting presenta
tion. It is an important effort to improve our knowledge in a very
unique surgical field, particularly when the data of the STICH trial
have been published, raising a lot of discussion. Before consideringgery c May 2010
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Dthe core of this presentation, it is correct in my mind to define the
surgical procedure named the Dor procedure. Considering this pro
cedure, as it has been done in Antonio’s presentation, as simple vol
umetric reduction is reductive and shows a limited knowledge of
the Dor procedure’s contribution. In the original article Dor pub
lished in 1988, the procedure is described as ‘‘endoventricular cir
cular patch plasty with septal exclusion.’’ The goal, as described in
this article, is exclusion of the septal akinetic segment, reorganizing
the remaining LV muscle without critically compromising the size
of the left ventricle. Therefore this technique deeply affects the sep
tal reshaping. Today, a series of new techniques have been pub
lished for surgical ventricular restoring, but the basic concept is
always the same as defined by Vincent Dor, even if people have
some difficulties admitting it.
In this article Dr Calafiore proposes a surgical technique to
preserve as much as possible an elliptical shape, and the results
are compared with those of a surgical technique defined as the stan
dard Dor procedure. I have 3 questions for Antonio.
First, according to your procedure, the length of the patch
depends on the distance between the highest point and the new
apex. How do you select the position of the new apex when the
entire apical zone is involved in LV dilatation and the longitudinal
diameter is elongated?
Dr Calafiore. Thank you, Lorenzo, for your questions. In the
normal heart the longitudinal diameter is made by 2 parts. The first
one goes from the base of the heart to the base of the papillary mus
cles; this part cannot be treated by means of surgical intervention.
The second part goes from the base of the papillary muscles to
the apex; this segment is approachable during surgical intervention.
In the normal heart the transverse diameter is roughly similar to
the distance from the base of the heart to the base of the papillary
muscle. The second distance is around 3 cm. When we have to
choose a new apex in patients with a transverse diameter larger
than normal, the new apex has to be positioned at least 5 cm
from the base of the papillary muscles, depending on the transverse
diameter and on the fixed part of the longitudinal diameter (base of
the heart base of the papillary muscles). This allows us to maintain
an acceptable sphericity index. If the scar is near the papillary mus
cle, the apex has to be in the scarred part. Then we need to include
the scar in the correction.
Dr Menicanti. Thank you. You conclude in your article that
a more physiologic elliptical shape improves the surgical results.
Unfortunately, as you say, the 2 groups of patients underwent
operations in 2 different periods. The 2 groups had the same base
line volume, but the reduction of the volume was different; 30%
was the reduction in group S against only 20% in group V. The
EF increased in 17% in group S against 7 in group V. CABG
was performed in 73% of group S versus 9% of group V.The Journal of Thoracic and CarIt seems tome that the groupVpatients had amore diffuse disease
than the group S patients, in whom a more localized dilatation is
present with a better contractility in the remote zone. This can ex
plain a good improvement of EF with fewer revascularizations.
Therefore the better result can be linked to a more important volume
reduction in the shape group. Can you comment on that?
Dr Calafiore. The volume reduction shown in the slides is the
volume reduction after roughly 5 years and not in the immediate
postoperative period. The difference in revascularization depends
on different surgical strategies. In the beginning, the left anterior
descending coronary artery was always grafted, even if the territory
was scarred. Today we never graft the left anterior descending
coronary artery if its territory is extensively scarred. The clinical
pattern of the patients we see today is worse than before because
the presence of akinetic areas with higher pulmonary pressures
reflects a clinical status in these patients that is worse than before.
In the past, surgical intervention was easier because the areas were
mainly dyskinetic. Today these patients are sicker than before
because the akinetic areas are predominant.
DrMenicanti. Finally, If the goal of the procedure is to exclude
all scars from the cavity, keeping a sphericity index in the normal
range, how do you avoid the risk of having too small a cavity at
the end of the procedure?
Dr Calafiore. The purpose of the correction is not to totally
eliminate the scar. You cannot completely eliminate the scar while
maintaining a conical heart. To avoid the excess or reduction of vol
ume, we modify not the length of the patch, which depends on the
position of the new apex, but its height, which depends on the initial
end diastolic volume. In the presence of large end diastolic vol
umes (80 mL/m2), we use a patch with a length/height ratio of
3:1. If the end diastolic volume is less than 80 mL/m2, we use
a larger patch with a ratio of 2:1. This strategy eliminates or reduces
at the maximum the possibility of a hypodiastolic syndrome.
Dr Menicanti. But this is determined by your experience?
Dr Calafiore. Of course.
Dr Menicanti. There are no rules?
Dr Calafiore. The only rule we follow is that the apex has to be
put in the scarred tissue to have a longitudinal diameter that is as
long as possible. Patients with apical akinesia can have a normal
life if the akinesia is concentrated just in the distal portion of the
left ventricle. We then prefer to have some scarring in the apex
rather than to eliminate all the scars but with the danger of having
a small cavity with a sphericity index that can approach 1.0.
Dr Menicanti. Do you think that is the approach with your
experience?
Dr Calafiore. I think so. I am not the only surgeon who is using
this technique.
Dr Menicanti. Thank you very much.diovascular Surgery c Volume 139, Number 5 1129
